e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Safety of and interactions between current treatments for asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Glucose and lactate concentrations in the distal lung are modified by hyperglycaemia and inflammation
Annika Åstrand (Mölndal, Sweden), Cecilia Nagorny Holmberg, Cecilia Wingren, Annika åstrand, John Taylor, James Garnett, Emma Baker, Deborah Baines
Source:
International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Session:
Safety of and interactions between current treatments for asthma and COPD
Session type:
Thematic Poster Session
Number:
1004
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Annika Åstrand (Mölndal, Sweden), Cecilia Nagorny Holmberg, Cecilia Wingren, Annika åstrand, John Taylor, James Garnett, Emma Baker, Deborah Baines. Glucose and lactate concentrations in the distal lung are modified by hyperglycaemia and inflammation. Eur Respir J 2015; 46: Suppl. 59, 1004
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Resistive breathing aggravates endotoxin-induced lung inflammation
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Muscle wasting in an acute Poly(I:C) and cigarette smoke-induced pulmonary inflammation mouse model
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014
Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Viral mimetic Poly(I:C) exacerbates cigarette smoke-induced pulmonary inflammation by facilitating the release of neutrophil-derived elastase
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
High fructose intake increases alveolar enlargement and muscle inflammation in mice exposed to cigarette smoke
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Non-invasive monitoring of emphysema and muscle wasting during experimental disease exacerbation
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Insulin resistance, lung function and exacerbation rate in chronic obstructive lung disease
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Monitoring oxidative stress during recovery from COPD exacerbations: Comparison of airway and systemic malondialdehyde levels
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Increased levels of apoptotic and necrotic markers during asthma exacerbation
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Endothelial dysfunction and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Serum adiponectin in hospitalised patients with COPD: Relationship with peripheral muscle function, physical performance and readmissions
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014
Systemic inflammation and exercise tolerance in COPD
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept